Transcend Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
10,321
-664
| -6% | -$84K | 0.1% | 181 |
|
|
2025
Q1 | $1.4M | Buy |
10,985
+27
| +0.2% | +$3.45K | 0.1% | 205 |
|
|
2024
Q4 | $1.45M | Buy |
10,958
+92
| +0.8% | +$12.2K | 0.1% | 192 |
|
|
2024
Q3 | $1.58M | Sell |
10,866
-41
| -0.4% | -$5.97K | 0.11% | 200 |
|
|
2024
Q2 | $1.5M | Sell |
10,907
-83
| -0.8% | -$11.4K | 0.11% | 195 |
|
|
2024
Q1 | $1.51M | Buy |
10,990
+15
| +0.1% | +$2.06K | 0.12% | 178 |
|
|
2023
Q4 | $1.49M | Buy |
10,975
+497
| +5% | +$67.5K | 0.13% | 168 |
|
|
2023
Q3 | $1.28M | Buy |
10,478
+400
| +4% | +$48.9K | 0.12% | 170 |
|
|
2023
Q2 | $1.28M | Buy |
10,078
+5,839
| +138% | +$741K | 0.12% | 177 |
|
|
2023
Q1 | $548K | Sell |
4,239
-1,605
| -27% | -$207K | 0.06% | 275 |
|
|
2022
Q4 | $767K | Buy |
5,844
+409
| +8% | +$53.7K | 0.08% | 225 |
|
|
2022
Q3 | $636K | Buy |
5,435
+1,124
| +26% | +$132K | 0.07% | 246 |
|
|
2022
Q2 | $507K | Sell |
4,311
-6,114
| -59% | -$719K | 0.05% | 293 |
|
|
2022
Q1 | $1.36M | Sell |
10,425
-10
| -0.1% | -$1.3K | 0.12% | 179 |
|
|
2021
Q4 | $1.59M | Buy |
10,435
+36
| +0.3% | +$5.5K | 0.14% | 165 |
|
|
2021
Q3 | $1.66M | Sell |
10,399
-401
| -4% | -$64.2K | 0.15% | 151 |
|
|
2021
Q2 | $1.76M | Buy |
10,800
+3,103
| +40% | +$506K | 0.25% | 99 |
|
|
2021
Q1 | $1.16M | Sell |
7,697
-231
| -3% | -$34.7K | 0.14% | 163 |
|
|
2020
Q4 | $1.2M | Sell |
7,928
-718
| -8% | -$109K | 0.16% | 146 |
|
|
2020
Q3 | $1.17M | Buy |
+8,646
| New | +$1.17M | 0.21% | 101 |
|
|
2020
Q2 | – | Sell |
-3,258
| Closed | -$351K | – | 151 |
|
|
2020
Q1 | $351K | Buy |
+3,258
| New | +$351K | 0.11% | 164 |
|